Completed
Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes
NCT00735501
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Copenhagen S, Denmark
- Stockholm, Sweden